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Abstract The mechanisms underlying targeted sorting of endo-
cytosed receptors for recycling to the plasma membrane or deg-
radation in lysosomes are poorly understood. In this report, the
C-terminal tails of the ¢ve dopamine receptors (D1^D5) were
expressed as glutathione S-transferase (GST) fusion proteins
and studied for their interaction with ezrin^radixin^moesin-
binding phosphoprotein 50 (EBP50) and N-ethylmaleimide-sen-
sitive factor (NSF), which are known to be involved in post-
endocytic recycling of receptors back to the plasma membrane,
and with sorting nexin 1 (SNX1), known to be involved in tar-
geting receptors to lysosomal degradation. EBP50 did not bind
any of the dopamine receptor tails. NSF bound strongly to D1
and D5 and only weakly to D2, D3 and D4. However, SNX1
clearly distinguished between D1 and D5, as only D5 bound
strongly to this protein. This report shows that there are distinct
interaction patterns for NSF and SNX1 to the various dopamine
receptor subtypes.
4 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Cloning of receptors for transmitters and hormones in the
eighties and nineties showed that the vast majority belong to
the G protein-coupled seven transmembrane segment (7TM)
receptor superfamily [1]. Although it was expected for many
transmitters that there would be receptor subtypes, the clon-
ing e¡ort resulted in a surprisingly large number of these, for
example: ¢ve homologous but distinct muscarinic acetylcho-
line receptors, four di¡erent histamine receptors, ¢ve di¡erent
somatostatin receptors and even 15 di¡erent serotonin, 5HT
receptors. In many cases we still do not have a good func-
tional ‘reason’ for the development of all these receptor sub-
types. Although receptor subtypes may bind synthetic ligands
or drugs di¡erently, they often recognize the endogenous li-
gand with rather similar a⁄nity. Di¡erent receptor subtypes
provide the possibility for a given transmitter or hormone to
utilize di¡erent signalling pathways. However, this specializa-
tion does not explain why, for example, there are two homol-
ogous dopamine receptors: D1 and D5 with long C-terminal
tails that couple to GKs, and three other, mutually homolo-
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Fig. 1. The D1-like (D1, D5) and D2-like (D2, D3, D4) 7TM recep-
tors have di¡erent signaling and endocytotic properties. A: Sche-
matic representation of the dopamine receptors in the plasma mem-
brane. D1, D2 and D5 are endocytosed upon agonist stimulation
and D1 and D2 are known to recycle back to the plasma mem-
brane. D3 and D4 are not endocytosed upon agonist stimulation.
B: Following agonist stimulation, many 7TM receptors are desensi-
tized and internalized into endosomes. In the sorting endosome,
proteins bind to the C-terminal tail of the 7TM receptor and either
recycle the receptor back to the plasma membrane (such as EBP50
and NSF in L2AR recycling) or target the receptor for degradation
in lysosomes (such as SNX1 in PAR1 receptor downregulation).
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gous dopamine receptors: D2, D3 and D4 with short C-ter-
minal tails that couple to GKi=o [2] (Fig. 1).
Although G proteins are key players in the function of
7TM receptors, a number of other accessory proteins such
as sca¡olding and adaptor proteins are also very important
in, for example, creating the infrastructure in which the re-
ceptors and their downstream e¡ector molecules function.
Binding domains in such adaptor proteins interact with rec-
ognition motifs often located in the C-terminal tails of the
receptors [3,4]. Interestingly, the structural homology among
receptor subtypes is highest in the transmembrane segments,
whereas especially the C-terminal tail regions can vary con-
siderably. Thus, it could be argued that one of the as yet
unnoticed di¡erentiating properties of many receptor subtypes
could be that they di¡er in their interactions with sca¡olding
and adaptor proteins. One important group of adaptor pro-
teins is involved in the post-endocytotic sorting of receptors
either in recycling back to the cell surface, which is the pre-
dominating pathway, or in the targeting to lysosomes for deg-
radation. Recently, two proteins have been proposed to be
involved in the recycling of the L2-adrenergic receptor
(L2AR). Ezrin^radixin^moesin-binding phosphoprotein 50
(EBP50) is the human homolog of rabbit NHERF (Naþ/
Hþ-exchanger regulatory factor) and binds to the cytoplasmic
tail of the L2AR through a PDZ domain [5]. This interaction
and hence the recycling of the receptor back to the membrane
is regulated by G protein-coupled receptor kinase 5 (GRK5)
phosphorylation of the receptor [5]. N-Ethylmaleimide-sensi-
tive factor (NSF), an ATPase involved in membrane vesicle
tra⁄cking, also binds to the cytoplasmic tail of the L2AR and
this interaction has been suggested to be necessary for both
internalization and recycling of the receptor [6]. Another pro-
tein, sorting nexin 1 (SNX1), which was originally identi¢ed
to interact with epidermal growth factor receptor was recently
shown to be responsible for the e⁄cient targeting of the
thrombin receptor PAR1 (protease-activated receptor 1)
from sorting endosomes to lysosomes [7]. In the present study
we investigate the binding of the puri¢ed C-terminal tails of
all ¢ve dopamine receptors with EBP50, NSF and SNX1.
2. Materials and methods
2.1. Materials
cDNA encoding rat NSF was provided by Jim Rothman by way of
Bob Lefkowitz, human EBP50 cDNA was provided by Mark von
Zastrow, and the cDNAs for the human D1 to D5 receptors were
provided by Hubert H.M. Van Tol.
2.2. Construction of GST fusion protein expression clones
To generate fusion proteins encoding the receptor C-terminal tails
and glutathione S-transferase (GST), the D1[334^446], D2[430^443],
D3[389^400], D4[450^467], D5[361^477] and L2-adrenergic[330^413]
receptor tails were ampli¢ed by PCR, digested with BamHI and
XhoI and ligated into the pGEX-4T-1 vector. Whereas non-fused
GST consists of 239 amino acids, the fusion constructs consist of
the ¢rst 224 amino acids of GST (including the BamHI site) followed
by the receptor C-terminal tails. This means that the molecular
weights of the GST tail fusions of D2, D3 and D4 with short C-
terminal tails are similar to the molecular weight of non-fused GST
(Fig. 2). Plasmids were transformed into XL1-Blue bacteria and the
DNA sequence veri¢ed by automated sequencing. Plasmids were
transformed into the Escherichia coli strain BL21 for protein expres-
sion. Bacterial fusion protein production was induced by addition of
0.2 mM isopropyl-1-thio-L-D-galactopyranoside for 4 h at 37‡C. Fu-
sion proteins were puri¢ed on glutathione Sepharose 4B beads as
described by the manufacturer (Amersham Pharmacia). The amount
of fusion protein on the beads was determined by comparison with
BSA standards on Coomassie-stained Bis^Tris polyacrylamide gel
electrophoresis (PAGE) gels (12% NuPage Bis^Tris gel, Invitrogen).
2.3. Synthesis of 35S-labeled sorting proteins
[35S]Methionine was incorporated into full-length EBP50, NSF and
SNX1 in a coupled in vitro transcription and translation reaction
according to the manufacturer’s instructions (Rabbit Reticulocyte Ly-
sate System, Promega L5010).
2.4. GST fusion protein binding assay
GST fusion protein on beads (3 Wg on 15 Wl settled beads, adjusted
with empty beads) was incubated with 500 Wl blocking bu¡er (20 mM
HEPES pH 7.4, 100 mM NaCl, 2 mM MgCl2, 0.1% Triton X-100, 1%
ovalbumin) for 30 min at room temperature. Beads were collected by
centrifugation (500Ug for 5 min) and 2 Wl of the in vitro translation
reaction mixture was added along with 18 Wl wash bu¡er (20 mM
HEPES pH 7.4, 100 mM NaCl, 2 mM MgCl2, 0.1% Triton X-100).
This mixture was vigorously mixed for 1 h at room temperature.
Beads were washed three times for 5 min in ice-cold wash bu¡er
and collected by centrifugation, eluted in 4Usodium dodecyl sulfate
sample bu¡er, and separated by Bis^Tris PAGE (12% NuPage Bis^
Tris gel, Invitrogen). Gels were Coomassie stained and dried over
night (DryEase Gel Drying System, Invitrogen). Fig. 2 shows that
each of the dopamine tail fusion constructs were present in roughly
equal amounts. Finally, radioactive bands on the gel were visualized
on a phosphor imager screen (Molecular Dynamics) and developed in
a molecular imager (BioRad). Quantitative determination of radio-
active band intensities was done with molecular imager software (Bio-
Rad) using background subtraction. Band intensities were subse-
quently normalized to the band intensity of the reference lane that
was loaded with 2 Wl of the in vitro translation reaction.
3. Results
3.1. EBP50 binding
EBP50 has been reported to bind to the L2AR [5]. We
con¢rmed this interaction in our system as the in vitro 35S-
labelled EBP50 protein bound strongly to the GST fusion of
the tail from the L2AR (Fig. 3). In contrast, the ¢ve di¡erent
GST-fused C-terminal tails from the dopamine receptors did
not pull down any signi¢cant amount of 35S-labelled EBP50
protein when compared with GST alone (Fig. 3). This sug-
gests that EBP50 is not involved in the recycling of any of the
¢ve dopamine receptor subtypes.
3.2. NSF binding
35S-labeled NSF protein bound strongly to the GST-fused
C-terminal tails of both the D1 and the D5 receptors (Fig. 4).
The GST fusions of the tails from the D2-like receptors, i.e.
D2, D3, and D4, did not pull down the 35S-labeled NSF
Fig. 2. Puri¢ed dopamine receptor C-terminal tails fused to GST.
Proteins were visualized by Coomassie staining. Theoretical molecu-
lar weights are GST^D1 (38.6 kDa), GST^D5 (39.5 kDa), GST^D2
(28.0 kDa), GST^D3 (27.8 kDa), GST^D4 (28.5 kDa) and GST
(27.9 kDa) (see Section 2).
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protein as e⁄ciently as the D1 and D5 tail fusions did. How-
ever, the D2-like receptors were able to pull down the 35S-
labeled NSF protein more e⁄ciently than GST alone (Fig. 4).
This was clearly not the case when 35S-labeled EBP50 was
used (Fig. 3). Thus, NSF binds e⁄ciently to the homologous
D1 and D5 receptors, but only weakly to the D2-like recep-
tors and NSF could therefore possibly be involved in the
recycling of especially the D1-like receptors.
3.3. SNX1 binding
SNX1 in contrast to EBP50 and NSF is believed to be
involved in lysosomal targeting of receptors. It binds strongly
to the C-terminal tail of the PAR1 receptor and targets it for
degradation [7]. As shown in Fig. 5, we found that among the
dopamine receptors, the 35S-labeled SNX1 protein bound
strongly only to the D5 receptor C-terminal tail. A weak
interaction was observed with the tail of the D1 and possibly
the D3 receptor (Fig. 5). These ¢ndings suggest the D5 recep-
tor, like the PAR1 receptor, may be sorted to lysosomal deg-
radation by SNX1.
4. Discussion
In the present study we have characterized the interaction
pattern of all ¢ve dopamine receptors with three proteins that
have been proposed to be involved in the post-endocytotic
sorting of receptors to be either recycled or targeted for deg-
radation. We ¢nd that the tails from the di¡erent subtypes of
receptors interact di¡erently with the adaptor proteins and
that, for example, the two homologous D1-like receptors,
which both signal through the same signal transduction path-
way, di¡er in their interaction with SNX1, which binds
strongly to the D5 receptor as opposed to the D1 receptor.
4.1. Internalization and recycling of dopamine receptors
Detailed information concerning internalization and post-
endocytotic events are mainly available for the D1, D2 and
D3 receptors (as summarized in Fig. 1). Initially, basic obser-
vations concerning desensitization etc. of the receptors were
described [8,9]. However, also more direct observations of the
agonist-induced endocytosis and recycling of D1 and D2 have
Fig. 3. Dopamine receptor C-terminals do not associate with EBP50 in GST pull-down assays. A: In vitro interaction of the C-terminus of the
L2AR and the dopamine receptors with 35S-labeled EBP50. Proteins were resolved by PAGE and radioactive bands visualized on a phosphor
imaging screen. The P and P10x lanes were loaded with 2 and 0.2 Wl respectively of the in vitro translation reaction. B: Band intensities were
normalized with the band intensity of the L2AR lane. The dashed line corresponds to the relative binding of EBP50 to GST protein alone. Re-
sults are representative of three independent pull-down experiments.
Fig. 4. Dopamine receptor C-terminals associate di¡erently with NSF in GST pull-down assays. A: In vitro interaction of the C-terminus of
the dopamine receptors with 35S-labeled NSF. Proteins were resolved by PAGE and radioactive bands visualized on a phosphor imaging screen.
The P and P10x lanes were loaded with 2 and 0.2 Wl respectively of the in vitro translation reaction. B: Band intensities were normalized with
the band intensity of the D1 lane. The dashed line corresponds to the relative binding of NSF to GST protein alone. Results are representative
of three independent pull-down experiments.
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been reported [10]. Analysis of surface biotinylated receptors
demonstrated that both the D1 and the D2 receptors after
endocytosis were e⁄ciently recycled to the plasma membrane
and with similar kinetics [10]. Interestingly, when studied in
Neuro2A neuroblastoma cells, the D1 and the D2 receptors
were targeted to di¡erent endocytic vesicles. In this system it
appeared that the D2 receptor to a certain degree was con-
stitutively internalized. Compared to the D2 receptor, the ho-
mologous D3 receptor is much less phosphorylated upon ag-
onist stimulation, has a very low ability to mobilize arrestin to
the plasma membrane and does not undergo agonist-induced
internalization [11]. The molecular pharmacological pheno-
type of the D2 and D3 receptors could be reversed with re-
spect to endocytosis through exchange of the second and third
intracellular loops of these two receptors [11]. The D4 recep-
tor does not internalize upon agonist stimulation [12].
4.2. Protein interaction with dopamine receptors
A number of proteins have been shown to interact with the
intracellular domains of the dopamine receptors, for example:
ABP-280 (actin-binding protein 280) [13,14], spinophilin [15],
and a novel protein called DRiP78 (dopamine receptor inter-
acting protein of 78 kDa), which appears to be involved in
receptor transport from the endoplasmic reticulum to the cell
surface [16]. By yeast two-hybrid assays, neuro¢lament-M was
recently shown to bind to the intracellular loop 3 of the D1
and D5 receptors, but not to the D2-like receptors [17]. It was
suggested that neuro¢lament-M is involved in cell surface ex-
pression and regulation of the D1-like receptors.
The present study adds NSF and SNX1 to the group of
‘DRiPs’, i.e. proteins that interact with the C-terminal tails of
the dopamine receptors. Based on the previously proposed
functional roles of these proteins, it is very likely that NSF
and SNX1 are involved in endocytosis and in post-endocytotic
sorting of the dopamine receptors, i.e. especially the D1 and
D5 receptors. It is very interesting that a similar interaction is
observed for the D1 and D5 receptors with NSF but that
SNX1 exclusively interacts with the D5 receptor (Fig. 5).
Very little is yet known about the cellular handling of the
D5 receptor besides that it undergoes ligand-induced endocy-
tosis similarly to the D1 receptor (Marc Caron, personal com-
munication). Our results could suggest that after internaliza-
tion, the D5 receptor may in the right cellular setting be
sorted to the lysosomal pathway in a similar way as the
PAR1 receptor [7]. Within neurons, the two D1-like receptors
are distributed di¡erently as the D1 receptor is found predom-
inantly in dendritic spines as opposed to the D5 receptor,
which accumulates in dendritic shafts [18,19]. Whether this
di¡erence has anything to do with the di¡erential interaction
of the D1 and D5 receptors with SNX1 remains to be inves-
tigated.
4.3. Biochemical versus cell biological studies
The biochemical studies in the present report obviously
cannot substitute for thorough cell biological studies of the
post-endocytotic sorting process as such. Thus, the present
biochemical studies should function as inspiration for subse-
quent direct cellular studies. However, certain issues require
that a direct biochemical approach be taken ^ at least initially.
For example, it is very hard to map on a receptor a recog-
nition motif for an adaptor molecule involved in the post-
endocytotic sorting by monitoring the cell biological event
as such because there may be an overlap with a recognition
motif for another adaptor protein involved in an earlier part
of the overall process. For example, if a mutation eliminates
arrestin binding, endocytosis will be blocked, and the e¡ect of
the mutation on the binding and function of a downstream
adaptor protein cannot be determined.
It should be noted that the interaction between receptor
and adaptor protein is highly regulated by receptor phosphor-
ylation. This is the case for the EBP50/L2AR interaction
which is speci¢cally disrupted as a result of GRK5-mediated
receptor phosphorylation [5]. In the dopamine receptor ¢eld,
it has been demonstrated that protein kinase A phosphoryla-
tion of a speci¢c threonine residue in intracellular loop 3
regulates a late step in the post-endocytotic targeting of the
receptor to a perinuclear region but is not required for the
initial ligand-mediated internalization as such [20].
Post-endocytotic sorting of receptors either to the rapid
recycling pathway or to lysosomes probably cannot be ex-
plained by the interaction of the receptor tails or intracellular
loops with a single adaptor protein. It is likely that several
Fig. 5. Dopamine receptor C-terminals associate di¡erently with SNX1 in GST pull-down assays. A: In vitro interaction of the C-terminus of
the dopamine receptors with 35S-labeled SNX1. Proteins were resolved by PAGE and radioactive bands visualized on a phosphor imaging
screen. The P and P10x lanes were loaded with 2 and 0.2 Wl respectively of the in vitro translation reaction. B: Band intensities were normalized
with the band intensity of the D5 lane. The dashed line corresponds to the relative binding of SNX1 to GST protein alone. Results are repre-
sentative of three independent pull-down experiments.
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proteins are involved in this sorting process and that the end
result for a given receptor depends on multiple factors includ-
ing the competition of several adaptor proteins at several
locations in the endocytotic pathway. It should be noted
that GST pull-down assays require binding a⁄nities in the
range of 100 nM to detect binding, and therefore some low-
a⁄nity protein^protein interactions may escape detection by
this approach. Recently a new protein called GASP (G pro-
tein-coupled receptor-associated sorting protein) was de-
scribed by Whistler and co-workers, which should be added
to the list of proteins involved in this important process [21].
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